Introduction: The Critical Role of Cap 1 in mRNA Therapeutics

As mRNA-based therapeutics and vaccines continue to reshape the future of medicine, mRNA capping enzymes have become a key component in ensuring stability, translational efficiency, and reduced immunogenicity. Among these, Cap 2'-O-methyltransferase plays a vital role in converting the Cap 0 structure to Cap 1 — a critical modification that enhances protein expression and improves mRNA safety.

What Is mRNA Cap 2'-O-Methyltransferase?

mRNA Cap 2'-O-methyltransferase is an essential enzyme that specifically methylates the ribose 2'-hydroxyl group of the first nucleotide adjacent to the cap structure. This modification transforms Cap 0 (m7GpppN) into Cap 1 (m7GpppNm), which closely mimics the natural eukaryotic mRNA structure. Cap 1 improves mRNA’s resistance to innate immune detection, reduces immunogenicity, and enhances translation, making it indispensable in mRNA vaccines, gene therapies, and synthetic biology.

Hzymes’ Cap 2'-O-Methyltransferase: Designed for Precision and Performance

Hzymes offers a GMP-grade Cap 2'-O-methyltransferase with outstanding enzymatic efficiency and purity. Manufactured to meet the highest standards, this enzyme is engineered for optimal performance in in vitro transcription (IVT) systems for research and commercial mRNA production.

Features:

• GMP-grade | DMF No. 036852 Free of animal-origin components, compliant with pharmaceutical manufacturing standards, and registered with a Drug Master File (DMF) for regulatory support.

• Ultra-low residue profile No nuclease residue, HCD, HCP, microorganism, metal ion, endotoxin.

• Superior stability The thermal stability is better than the imported products.

• High enzymatic activity and purity

The enzyme activity is higher than similar competing products, and the protein purity is as high as 99%

Performance

Maximize image

Edit image

Delete image

Maximize image

Edit image

Delete image

(Left) Thin layer chromatography (TLC) of non-radioactive standards.

(Right) Spectrophotometry determination of radioactive phosphor, P32, showing that the substrate has been basically all modified into cap0 and cap1 structure after the oftimazation of enzymatic reaction system

Applications in mRNA Manufacturing

Hzymes' Cap 2'-O-methyltransferase is widely applicable in:

• mRNA vaccine development

• Therapeutic protein expression

• Gene editing tools (e.g., CRISPR-based systems)

• Synthetic mRNA production for research or clinical trials

The enzyme integrates seamlessly into IVT workflows, delivering reliable Cap 1 formation that meets pharmaceutical quality standards.

Why Choose Hzymes for mRNA Capping Enzymes?

• Trusted GMP-grade source with DMF support

• Optimized enzyme formulation for maximum capping efficiency

• High-purity, high-activity enzyme for translational success

• Excellent batch-to-batch consistency for scale-up and reproducibility

Hzymes is committed to advancing mRNA technology through innovative enzyme solutions tailored to modern biotechnology needs.

Conclusion

As the demand for high-quality mRNA therapeutics grows, precise and efficient capping enzymes become indispensable. Hzymes’ mRNA Cap 2'-O-methyltransferase offers the high purity, activity, and regulatory compliance necessary to support next-generation mRNA development. From lab-scale experiments to GMP-grade manufacturing, Hzymes provides the tools needed to ensure success in every step of your mRNA journey.